Dermatology · Philadelphia, PA
NPI
1225475734
Since 2013
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1025 Walnut St, Suite 701
Philadelphia, PA, 19107
Phone (215) 955-6180
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
739 services
Medicare patients, 2024
251
Average age 73
Drug cost, 2024
$911K
291 prescriptions
Company payments, 2025
$3,367
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neda Nikbakht was code 17003 (destruction skin lesion), 186 times for 41 patients. In total Neda Nikbakht billed 739 services in 26 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Facility | 186 | 41 | $1.60 | $298 |
| 99214 Office E&M - Established | Facility | 125 | 97 | $67.92 | $8,491 |
| 99213 Office E&M - Established | Facility | 82 | 78 | $46.39 | $3,804 |
| 17000 Destruction Skin Lesion | Facility | 74 | 60 | $38.81 | $2,872 |
| 99215 Office E&M - Established | Facility | 61 | 34 | $112.47 | $6,861 |
| 11102 Skin Biopsy | Facility | 52 | 44 | $24.01 | $1,249 |
| 17110 Destruction Skin Lesion | Facility | 36 | 32 | $52.06 | $1,874 |
| 99203 Office E&M - New | Facility | 30 | 30 | $56.46 | $1,694 |
| 11103 Skin Biopsy | Facility | 22 | 18 | $16.01 | $352 |
| 99204 Office E&M - New | Facility | 15 | 15 | $107.67 | $1,615 |
By year: 2022 $33K for 636 services; 2023 $35K for 807 services; 2024 $32K for 739 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neda Nikbakht prescribed most often to Medicare patients was Triamcinolone Acetonide, with 45 prescriptions and refills. In total Neda Nikbakht wrote 291 Medicare prescriptions that cost $911K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 45 | 55 | 16 | $767 |
| Clobetasol Propionate Generic | 28 | 33 | Under 11 | $864 |
| Tacrolimus Generic | 25 | 29 | Under 11 | $3,224 |
| Ketoconazole Generic | 20 | 20 | Under 11 | $222 |
| Valchlor Mechlorethamine Hcl | 14 | 18 | Under 11 | $172K |
| Cosentyx Unoready Pen Secukinumab | 11 | 11 | Under 11 | $77K |
| Bexarotene Generic | 11 | 16 | Under 11 | $215K |
Brand drugs: 81 claims; generic drugs: 210 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neda Nikbakht $3,367 ($3,367 in general payments such as food, travel and fees) from 3 companies. The largest payer was Helsinn Therapeutics (U.S.), Inc. with $3,185.
| Company | Payments | Amount |
|---|---|---|
| Helsinn Therapeutics (U.S.), Inc. | 3 | $3,185 |
| Kyowa Kirin, Inc. 4151.T | 4 | $182 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.